ADENTRA Inc

As of June 30, 2026, ADENTRA Inc carries a market capitalization of 931.89M, placing it among publicly traded companies globally. Its enterprise value stands at 1.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

ADENTRA Inc's next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, ADENTRA Inc has 24.11M shares outstanding.

As of June 30, 2026, ADENTRA Inc trades at a trailing price-to-earnings ratio of 9.76. The price-to-sales ratio is 0.29, and the price-to-book ratio stands at 0.95.

As of June 30, 2026, ADENTRA Inc trades at an EV/EBITDA multiple of 6.77 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.64 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. ADENTRA Inc trades at an EV/FCF ratio of 6.84, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.80B versus a market cap of 931.89M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, ADENTRA Inc maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 89.31, indicating elevated leverage, while an interest coverage ratio of 4.56 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ADENTRA Inc posted a return on equity (ROE) of 10.15, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.61 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.56, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.27, useful for judging operating efficiency across full business cycles. The company generates approximately 1.09M in revenue per employee across its workforce of 2,956.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.10 indicates how many times ADENTRA Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, ADENTRA Inc recorded 19,868.94 in income tax expense. That works out to an effective tax rate of 0.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 96.22M, leaving 96.20M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, ADENTRA Inc's stock has gained approximately 0.67% over the past 52 weeks. The 50-day moving average sits at 35.76, while the 200-day moving average is 35.76.

Over the twelve months ended June 30, 2026, ADENTRA Inc generated 3.23B in revenue and converted that into 96.20M in net income, yielding earnings per share of 3.89. EBITDA reached 265.60M, while operating income came in at 142.26M.

As of June 30, 2026, ADENTRA Inc holds 6.47M in cash and equivalents against 872.17M in total debt, resulting in a net debt position of 516.17M. Total book value stands at 976.57M, with working capital of 452.90M providing operational flexibility.

ADENTRA Inc produced 222.92M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -18.32M in capital expenditures, free cash flow totaled 204.60M - equivalent to 8.42 per share.

Over the twelve months ended June 30, 2026, ADENTRA Inc posted a gross margin of 21.40, reflecting its pricing power and cost economics. The operating margin of 4.40 and net profit margin of 2.97 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, ADENTRA Inc paid dividends of 0.64 per share. The dividend payout ratio of 16.12 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 21.43, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 22.82, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to ADENTRA Inc shareholders.

As of June 30, 2026, ADENTRA Inc has an Altman Z-Score of 4.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.